Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00142831 · ClinicalTrials.gov registry record · Phase 4
Bupropion as an Adjunct to the Nicotine Patch Plus CBT
A Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 4
- Development phase
- 293
- Enrollment target
NCT00142831: Completed Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00142831 is a Phase 4 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 293 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00142831, a Phase 4 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 293 participants
- Enrollment target
Study Summary
Existing and new pharmacotherapies along with prevention efforts are key to improving smoking cessation rates and reducing the premature morbidity and mortality associated with tobacco use. A number of individuals suffer from both nicotine dependence and depression. The purpose of this study is to determine the effectiveness of bupropion used in combination with the nicotine replacement patch and cognitive behavior therapy (CBT) in treating nicotine dependent individuals also diagnosed with depression.
Interventions
- DRUG Pharmacotherapies for Smoking Cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 293 participants |
| Start Date | 1999-04 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
What the finished NCT00142831 record still lists
NCT00142831 is an interventional study that assigns participants to a tested intervention. The registered 293 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 1 intervention - of which Pharmacotherapies for Smoking Cessation is the first listed.
NCT00142831 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00142831 about?
NCT00142831 is a clinical study titled "Bupropion as an Adjunct to the Nicotine Patch Plus CBT". Existing and new pharmacotherapies along with prevention efforts are key to improving smoking cessation rates and reducing the premature morbidity and mortality associated with tobacco use. A number of individuals suffer from both nicotine dependence and depression. The purpose of this study is to d...
What is the current status of trial NCT00142831?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 293 participants. The study started on 1999-04. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00142831?
The interventions under investigation include: Pharmacotherapies for Smoking Cessation (DRUG).
Who is sponsoring clinical trial NCT00142831?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00142831's enrollment target sits among peer trials
293 296th of 2000 higher than 1,705 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia